Contact Us
|
Client Login
PRODUCTS & SERVICES
Antibody Products
Antibody Products Store
Neuroscience
Epitope Tags
Structural Proteins & Cell Components
Signal Transduction
Immunopathology
Detection Chemistries & Ancillaries
Custom Immunology Services
Clinical Services
Bioanalytical
Central Laboratory
Clinical Development (Phase I-III)
Discovery & Translational Services
Antibody Products
Biomarker Center of Excellence
BioPathways
Computational Biology
Discovery
Genomics Laboratory
Immunology
Vaccines & Infectious Disease
Nonclinical Services
Antibody Products
Bioanalytical Services
Discovery
Drug Metabolism & Pharmacokinetics
Immunology
Radiosynthesis
Research Models
Safety Pharmacology
Toxicology
Vaccines & Infectious Disease
Biopharmaceutical CMC Solutions
Biorepository Services
Environmental Sciences
Genomics Laboratory
Integration in Drug Development
Market Access
Nutritional Chemistry & Food Safety
Secure Data Access
Strategic Partnering
CAREERS
Search Jobs
College / University
Featured Jobs
Diversity
Benefits
现在就加入科文斯
STUDY PARTICIPANTS
INVESTORS
Investor Information
Investor Home
Stock Information
Board of Directors
Corporate Governance Guidelines
Analyst Coverage
Investor FAQ
Presentations & Webcasts
Financial Information
SEC Filings
Annual Reports
Press Releases
Calendar of Events
Request Information
NEWS
Press Releases
Media Relations
ABOUT COVANCE
Company Overview
Global Locations
Corporate Responsibility
Business Integrity Program
Animal Welfare
Covance.Asia
RESOURCE CENTER
Blog
Investors
Investor Information
Financial Information
SEC Filings
Annual Reports
Press Releases
Calendar of Events
Request Information
Home
> Investors >
Financial Information
>
Press Releases
Financial Information
Press Releases
2004
|
2005
|
2006
|
2007
|
2008
|
2009
|
2010
|
2011
|
2012
|
2013
Date
Title
29-Nov-2010
Covance Announces Key Executive Promotions and Appointment
Print
09-Nov-2010
Covance Announces $250 Million Accelerated Share Repurchase
Print
03-Nov-2010
Covance Reports Third Quarter Financial Results and Takes Actions to Strengthen Future Performance
Print
29-Oct-2010
Covance and sanofi-aventis Finalize Agreements for 10-year Strategic R&D Alliance
Print
12-Oct-2010
Covance Announces Exclusive Relationship with INphoton, LLC For Microscopy Imaging Services
Print
30-Sep-2010
Covance and Sanofi-Aventis Sign Definitive Agreements for 10-Year Strategic R&D Alliance
Print
28-Sep-2010
Covance Board Authorizes $250 Million Stock Buyback
Print
28-Jul-2010
Covance Reports Second Quarter Revenue of $475M and EPS of $0.49; Updates Full-Year Financial Targets
Print
08-Jun-2010
Covance Expands Service Offerings With New Biorepository Facility
Print
10-May-2010
Covance Establishes New Discovery & Translational Services Group
Print
06-May-2010
Covance Appoints Dr. Douglas M. Fast to Head Global Bioanalytical
Print
28-Apr-2010
Covance Reports First Quarter Revenue of $482M and EPS of $0.60; Updates Full Year Financial Targets
Print
26-Feb-2010
Lilly, Covance Strategic Alliance Proves Win-Win For Both Companies, Patients
Print
27-Jan-2010
Covance Reports Fourth Quarter Revenue of $485M and EPS of $0.64 Per Share
Print
Home
|
Animal Welfare
|
Privacy Policy
|
Contact Us
|
Site Map
|
Investigators
|
Covance.Asia
RSS
© Copyright 2013 Covance Inc. All rights reserved.